The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic areas—cardiovascular disease, central nervous system (CNS) disorders, and pain—in LatAm and Viatris’ aim to partner with local stakeholders and go beyond providing medicines to address deeper patient journey issues in the region.
Latin America is a critical region and part of the emerging markets that can contribute to business growth, but also offer talent and diversity.
